OTEZLA XR Trademark

Trademark Overview

On Wednesday, May 3, 2017, a trademark application was filed for OTEZLA XR with the United States Patent and Trademark Office. The USPTO has given the OTEZLA XR trademark a serial number of 87435658. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 30, 2020. This trademark is owned by Celgene Corporation. The OTEZLA XR trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of chronic inflammatory diseases, ankylosing spondylitis, psoriasis, psoriatic arthritis and cancer
otezla xr

General Information

Serial Number87435658
Word MarkOTEZLA XR
Filing DateWednesday, May 3, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 30, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 29, 2017

Trademark Statements

Indication of Colors claimedThe color(s) blue, gold and orange is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"XR"
Description of MarkThe mark consists of gold and orange diamond shape with a single blue wave piercing the bottom of the diamond. All to the upper left of the word "OTEZLA" in blue and "XR" in orange. The white appearing in the mark represents background or transparent area and is not a part of the mark.
Goods and Servicespharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of chronic inflammatory diseases, ankylosing spondylitis, psoriasis, psoriatic arthritis and cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 9, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAMGEN INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Monday, November 30, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 30, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 3, 2020REVIEW OF CORRESPONDENCE COMPLETE
Wednesday, May 27, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 27, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 27, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 22, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 23, 2020EXTENSION 5 GRANTED
Tuesday, March 17, 2020EXTENSION 5 FILED
Monday, March 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 17, 2020TEAS EXTENSION RECEIVED
Tuesday, September 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2019EXTENSION 4 GRANTED
Friday, September 20, 2019EXTENSION 4 FILED
Friday, September 20, 2019TEAS EXTENSION RECEIVED
Wednesday, February 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 25, 2019EXTENSION 3 GRANTED
Monday, February 25, 2019EXTENSION 3 FILED
Monday, February 25, 2019TEAS EXTENSION RECEIVED
Thursday, September 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 18, 2018EXTENSION 2 GRANTED
Tuesday, September 18, 2018EXTENSION 2 FILED
Tuesday, September 18, 2018TEAS EXTENSION RECEIVED
Tuesday, July 10, 2018ASSIGNED TO EXAMINER
Thursday, March 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 27, 2018EXTENSION 1 GRANTED
Tuesday, February 27, 2018EXTENSION 1 FILED
Tuesday, February 27, 2018TEAS EXTENSION RECEIVED
Tuesday, October 24, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 29, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 29, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 9, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2017ASSIGNED TO LIE
Monday, July 17, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 17, 2017EXAMINER'S AMENDMENT ENTERED
Monday, July 17, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 17, 2017EXAMINERS AMENDMENT E-MAILED
Monday, July 17, 2017EXAMINERS AMENDMENT -WRITTEN
Sunday, July 16, 2017ASSIGNED TO EXAMINER
Wednesday, May 10, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, May 9, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 6, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

otezla preparations pharmaceutical ankylosing diseases spondylitis psoriatic cancer arthritis inflammatory psoriasis